To investigate the CGD disease phenotype in the same, and therefore comparable, genetic background, we introduced the p47-ΔGT mutation into a well-characterized iPSC line derived from CD34+ blood cells (Ackermann et al., 2014). This evidence concerns the gene CD34 and chronic granulomatous disease.